Clinical trial
Treatment of Persistent Wheezing in Infants and Children
NCT00301171 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00301171 |
|---|---|
| Title | Treatment of Persistent Wheezing in Infants and Children |
| Official title | Respiratory Function in Infants With Persistent Wheezing |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Asthma, Respiratory Sounds |
| Intervention type | Drug |
| Interventions | Inhaled Fluticasone |
| Enrollment | 54 |
| Start date | Sep 1, 2003 |
| Completion | Aug 1, 2007 |
| First posted | Mar 10, 2006 |
| Last update posted | Jul 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: